© The Author [2007].
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
Foreword
Eurodial, Euromedic, Dialysis Unit, Leiria, Portugal
Correspondence: E-mail: fcarrera@mail.telepac.pt
Received for publication July 17, 2007. Accepted for publication September 10, 2007.
| The first 10% of the full text of this article appears below. |
Secondary hyperparathyroidism (SHPT) develops in chronic kidney disease (CKD) as a consequence of disturbances in mineral metabolism and vitamin D synthesis [1]. Alterations in signalling via the parathyroid gland calcium-sensing receptor (CaR) are known to play a central role in the development of SHPT [2,3], making